Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience. uri icon

Overview

abstract

  • This letter to the editor describes myocarditis screening among patients undergoing combination immune checkpoint inhibitor therapy, in light of the consensus document from the Checkpoint Inhibitor Safety Working Group.

publication date

  • March 25, 2019

Research

keywords

  • Immunotherapy
  • Melanoma
  • Myocarditis

Identity

PubMed Central ID

  • PMC6516118

Scopus Document Identifier

  • 85063384871

Digital Object Identifier (DOI)

  • 10.1634/theoncologist.2019-0040

PubMed ID

  • 30910868

Additional Document Info

volume

  • 24

issue

  • 5